<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
<% signal.analyst %>
Last Updated: Feb 09, 2026 04:19:32 PM (GMT)
CVS: The current market price is 78.81 with no percentage change from the previous close.
Support and Resistance Levels Three support levels are 76.81, 77.81, and 78.00, with resistance levels at 79.00, 79.50, and 80.00. The pivot point is 78.00.
Indicators RSI is at 100, indicating overbought conditions. The Parabolic SAR remains constant at 78.81, while ATR and ADX show no values. SMA and EMA are all consistently at 78.81.
Market Sentiment The market price is above the pivot point (78.00), suggesting a bullish trend supported by the RSI and SMA indicators.
About (cvs) CVS Health Corporation
```htmlCompany Background
CVS Health Corporation, trading under the symbol CVS on the NYSE, is a leading healthcare company in the United States, committed to improving health outcomes and enhancing patient care. Established in 1963, CVS has grown from a local pharmacy into a comprehensive healthcare provider, offering an extensive array of services that include retail pharmacy, pharmacy benefits management (PBM), and health insurance through its Aetna division. The company's mission revolves around helping people on their path to better health by providing accessible, cost-effective, and high-quality healthcare solutions.
Market Position
As one of the largest integrated healthcare providers in the U.S., CVS Health holds a significant market position, bolstered by its extensive network of over 9,900 retail locations and more than 1,100 walk-in medical clinics. The company has successfully diversified its offerings, leveraging its PBM services to manage prescription drug benefits for over 100 million members. CVS Health's acquisition of Aetna in 2018 further solidified its role in the healthcare ecosystem, allowing it to provide a unique combination of pharmacy services and health insurance solutions, making it a formidable player in the competitive healthcare landscape.
Key Financial Highlights
In recent years, CVS Health has demonstrated strong financial performance, highlighted by robust revenue growth and a commitment to shareholder value. The company reported revenues exceeding $300 billion in 2022, marking a sustained upward trajectory fueled by strategic investments and expansion initiatives. CVS Health maintains a strong balance sheet, with a focus on reducing debt levels while investing in technology and innovation to enhance customer experience. The company's strategic vision emphasizes an integrated approach to healthcare, positioning it well to capitalize on the increasing demand for comprehensive health services as the industry evolves.
Industry Highlights
CVS Health operates within a rapidly changing healthcare environment, characterized by an increasing emphasis on value-based care and patient-centered services. With the ongoing digital transformation in healthcare delivery, CVS Health is actively investing in telehealth services and digital health tools, ensuring it remains at the forefront of industry advancements. The company's commitment to social responsibility and community health initiatives further distinguishes it in the marketplace, fostering trust and loyalty among its diverse customer base.
```Related Stocks
Sidebar rates
- <% signal.pair %>
<% signals.active.Current.rate.substr(0,7) %>
